CAPOTEN captopril 5mg/mL oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

capoten captopril 5mg/ml oral liquid bottle

arrotex pharmaceuticals pty ltd - captopril, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: sodium benzoate; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; disodium edetate; purified water; citric acid - 1.hypertension: capoten (captopril) is indicated for the treatment of hypertension. in using capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see precautions). capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive. 2. myocardial infarction: capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. the efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. heart failure: capoten (captopril) is indicated for the treatment of heart failure. in symptomatic patients it is recommended that capoten be administered together with a diuretic. 4. diabetic nephropathy: capoten is indicated for the treatment of diabetic nephropathy in patients with type 1 insulin- dependent diabetes mellitus.

KEFLOR cefaclor 250mg/5mL (as monohydrate) powder for oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

keflor cefaclor 250mg/5ml (as monohydrate) powder for oral liquid bottle

alphapharm pty ltd - cefaclor monohydrate, quantity: 52.45 mg/ml (equivalent: cefaclor, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: methylcellulose; sodium lauryl sulfate; dimeticone 350; xanthan gum; erythrosine; sucrose; pregelatinised starch; flavour - keflor is indicated for the treatment of the following types of infections caused by or likely to be caused susceptible organisms: lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory infections, including pharyngitis, tonsillitis and otitis media. skin and skin structure infections. urinary tract infections, including pyelonephritis and cystitis. note: 1. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. keflor appears to be effective as phenoxymethul penicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever are not available at present. 2. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organisms to cefaclor.

KEFLOR cefaclor 125mg/5mL (as monohydrate) powder for oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

keflor cefaclor 125mg/5ml (as monohydrate) powder for oral liquid bottle

alphapharm pty ltd - cefaclor monohydrate, quantity: 26.22 mg/ml (equivalent: cefaclor, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: methylcellulose; sodium lauryl sulfate; dimeticone 350; xanthan gum; erythrosine; sucrose; pregelatinised starch; flavour - keflor is indicated for the treatment of the following types of infections caused by or likely to be caused susceptible organisms: lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory infections, including pharyngitis, tonsillitis and otitis media. skin and skin structure infections. urinary tract infections, including pyelonephritis and cystitis. note: 1. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. keflor appears to be effective as phenoxymethul penicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever are not available at present. 2. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organisms to cefaclor.

RIXADONE risperidone 1 mg/mL oral liquid solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

rixadone risperidone 1 mg/ml oral liquid solution bottle

boucher & muir pty ltd - risperidone, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: tartaric acid; benzoic acid; purified water; hydrochloric acid - rixadone is indicated for the treatment of schizophrenia and related psychoses.,rixadone is indicated for the short-term treatment of acute mania associated with bipolar 1 disorder.,rixadone is indicated for the treatment (up to 12 weeks) of psychotic symptoms, or persistent agitation or aggression unresponsive to non-pharmacological approaches in patients with moderate to severe dementia of the alzheimer type.,rixadone is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.,rixadone is indicated for the treatment of behavioural disorders associated with autism in children and adolescents.

GAVISCON peppermint flavour oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

gaviscon peppermint flavour oral liquid bottle

reckitt benckiser pty ltd - sodium bicarbonate, quantity: 26.7 mg/ml; calcium carbonate, quantity: 16 mg/ml; sodium alginate, quantity: 50 mg/ml - oral liquid, suspension - excipient ingredients: carbomer homopolymer (type b); propyl hydroxybenzoate; sodium hydroxide; saccharin sodium; peppermint oil; purified water; methyl hydroxybenzoate - fast, soothing, long lasting relief from heartburn and acid indigestion.

GAVISCON DUAL ACTION LIQUID SACHETS oral liquid suspension sachet Australia - English - Department of Health (Therapeutic Goods Administration)

gaviscon dual action liquid sachets oral liquid suspension sachet

reckitt benckiser pty ltd - sodium alginate, quantity: 50 mg/ml; calcium carbonate, quantity: 32.5 mg/ml; sodium bicarbonate, quantity: 21.3 mg/ml - oral liquid, suspension - excipient ingredients: propyl hydroxybenzoate; purified water; sodium hydroxide; methyl hydroxybenzoate; carbomer homopolymer (type b); saccharin sodium; flavour - fast, soothing, long lasting relief from heartburn and acid indigestion.

GAVISCON LIQUID POCKET PACKS PEPPERMINT oral liquid suspension sachet Australia - English - Department of Health (Therapeutic Goods Administration)

gaviscon liquid pocket packs peppermint oral liquid suspension sachet

reckitt benckiser pty ltd - sodium bicarbonate, quantity: 26.7 mg/ml; sodium alginate, quantity: 50 mg/ml; calcium carbonate, quantity: 16 mg/ml - oral liquid - excipient ingredients: saccharin sodium; purified water; methyl hydroxybenzoate; carbomer homopolymer (type b); propyl hydroxybenzoate; sodium hydroxide; flavour - fast, soothing, long lasting relief from heartburn and acid indigestion.

Copy of GAVISCON DUAL ACTION peppermint flavour oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

copy of gaviscon dual action peppermint flavour oral liquid bottle

reckitt benckiser pty ltd - calcium carbonate, quantity: 32.5 mg/ml; sodium bicarbonate, quantity: 21.3 mg/ml; sodium alginate, quantity: 50 mg/ml - oral liquid, suspension - excipient ingredients: purified water; propyl hydroxybenzoate; sodium hydroxide; methyl hydroxybenzoate; saccharin sodium; carbomer homopolymer (type b); flavour - fast, soothing, long lasting relief from heartburn and acid indigestion.

GAVISCON COOL cool mint flavour oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

gaviscon cool cool mint flavour oral liquid bottle

reckitt benckiser pty ltd - sodium bicarbonate, quantity: 26.7 mg/ml; sodium alginate, quantity: 50 mg/ml; calcium carbonate, quantity: 16 mg/ml - oral liquid, suspension - excipient ingredients: purified water; saccharin sodium; sodium hydroxide; propyl hydroxybenzoate; methyl hydroxybenzoate; carbomer 934p; flavour - fast, soothing, long lasting relief from heartburn and acid indigestion.

GAVISCON aniseed flavour oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

gaviscon aniseed flavour oral liquid bottle

reckitt benckiser pty ltd - sodium alginate, quantity: 50 mg/ml; sodium bicarbonate, quantity: 26.7 mg/ml; calcium carbonate, quantity: 16 mg/ml - oral liquid, suspension - excipient ingredients: erythrosine; purified water; carbomer homopolymer (type b); methyl hydroxybenzoate; propyl hydroxybenzoate; saccharin sodium; sodium hydroxide; flavour - fast, soothing, long lasting relief from heartburn and acid indigestion